{"Title": "Old medications and new targeted therapies in systemic sclerosis", "Year": 2015, "Source": "Rheumatology", "Volume": "54", "Issue": 11, "Art.No": null, "PageStart": 1944, "PageEnd": 1953, "CitedBy": 28, "DOI": "10.1093/rheumatology/keu285", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84946706774&origin=inward", "Abstract": "\u00a9 The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.SSc is a multiorgan disease with significant morbidity that is associated with poor health-related quality of life. Treatment of this condition is often organ based and non-curative. However, there are newer, potentially disease-modifying therapies available to treat certain aspects of the disease. This review focuses on old and new therapies in the management of SSc in clinical practice.", "AuthorKeywords": ["Digital ulcers", "Immunosuppressive therapy", "Interstitial lung disease", "Pulmonary arterial hypertension", "Raynaud's phenomenon", "Renal crisis", "Skin fibrosis", "Systemic sclerosis", "Treatment"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84946706774", "SubjectAreas": [["Rheumatology", "MEDI", "2745"], ["Pharmacology (medical)", "MEDI", "2736"]], "AuthorData": {"37117677200": {"Name": "Nagaraja V.", "AuthorID": "37117677200", "AffiliationID": "60025778", "AffiliationName": "Division of Rheumatology, University of Michigan"}, "24066781200": {"Name": "Khanna D.", "AuthorID": "24066781200", "AffiliationID": "60025778", "AffiliationName": "Division of Rheumatology, University of Michigan"}, "7006031021": {"Name": "Denton C.", "AuthorID": "7006031021", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, University College London"}}}